Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy

被引：52

作者：

Mariani, Paul G.

Sader, Helio S. ^{[1
]}

Jones, Ronald N.

机构：

[1] JMI Labs, N Liberty, IA 52317 USA

[2] Meritcare Hosp, Fargo, ND USA

[3] Tufts Univ, Sch Med, Boston, MA 02111 USA

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2006年 / 58卷 / 02期

关键词：

S; aureus; resistance; glycopeptides; cyclic lipopeptides;

D O I：

10.1093/jac/dkl256

中图分类号：

R51 [传染病];

学科分类号：

100401 [流行病与卫生统计学];

摘要：

引用

页码：481 / 483

页数：3

共 6 条

[1]

*CLIN LAB STAND I, 2006, PERF STAND ANT SUSC

[2]

Correlation between reduced daptomycin susceptibility and vancomycin resistance in vancomycin-intermediate Staphylococcus aureus [J].

Cui, LZ ;

Tominaga, E ;

Neoh, HM ;

Hiramatsu, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (03) :1079-1082

[3]

COMPARATIVE-EVALUATION OF DAPTOMYCIN (LY146032) AND VANCOMYCIN IN THE TREATMENT OF EXPERIMENTAL METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS OSTEOMYELITIS IN RABBITS [J].

MADER, JT ;

ADAMS, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (05) :689-692

[4]

MALABARTA A, 2005, J ANTIMICROB CHEM S2, V55

[5]

Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin [J].

Sakoulas, G ;

Alder, J ;

Thauvin-Eliopouios, C ;

Moellering, RC ;

Eliopoulos, GM .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1581-1585

[6]

A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital [J].

Wootton, M ;

Howe, RA ;

Hillman, R ;

Walsh, TR ;

Bennett, PM ;

MacGowan, AP .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 47 (04) :399-403

← 1 →